Garth Cumberlidge, PhD

President & CEO

Chairman of Eyevensys SAS and former CEO of Mimetogen Pharmaceuticals. Successful track record of ophthalmology drug development, fund-raising and licensing.

Przemyslaw(Mike) Sapieha, Ph.D

Founder & Chief Scientific Officer

Director of the Neurovascular Eye Disease Lab at Maisonneuve-Rosemont Hospital Research Centre and Wolfe Professor of translational vision research, Canada Research Chair in retina...